Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Benylin with Codeine oral solution
030902040BBACA0
|
Benylin | Diphenhydramine hydrochloride | Respiratory System | No data available |
|
Benzalkonium chloride 0.198% spray
1311030D0AAAFAF
|
Benzalkonium chloride (Solution/spray) | Benzalkonium chloride | Skin | No data available |
|
Benzalkonium chloride 1% solution
1311030D0AAABAB
|
Benzalkonium chloride (Solution/spray) | Benzalkonium chloride | Skin | No data available |
|
Benzalkonium chloride 500microgram lozenges sugar free
1203030T0AAAAAA
|
Benzalkonium chloride (Lozenge) | Benzalkonium chloride | Ear, Nose and Oropharynx | No data available |
|
Benzamycin gel
1306010C0BWAAAY
|
Benzamycin | Benzoyl peroxide | Skin | No data available |
|
Benzatropine 1mg tablets
0409020E0AAADAD
|
Benzatropine mesilate | Benzatropine mesilate | Central Nervous System | No data available |
|
Benzatropine 1mg/5ml oral solution
0409020E0AAACAC
|
Benzatropine mesilate | Benzatropine mesilate | Central Nervous System | No data available |
|
Benzatropine 2mg/2ml solution for injection ampoules
0409020E0AAAAAA
|
Benzatropine mesilate | Benzatropine mesilate | Central Nervous System | No data available |
|
Benznidazole 50mg tablets
0504060B0AAAAAA
|
Benznidazole | Benznidazole | Infections | No data available |
|
Benzocaine 0.5% / Triclosan 0.2% lotion
1303000B0AAACAC
|
Benzocaine (Topical) | Benzocaine | Skin | No data available |
|
Benzocaine 1% / Mepyramine 0.5% spray
1303000B0AAAJAJ
|
Benzocaine (Topical) | Benzocaine | Skin | No data available |
|
Benzocaine 1% / Triclosan 0.2% cream
1303000B0AAABAB
|
Benzocaine (Topical) | Benzocaine | Skin | No data available |
|
Benzocaine 1% spray
1303000B0AAAIAI
|
Benzocaine (Topical) | Benzocaine | Skin | No data available |
|
Benzocaine 10mg / Cetylpyridinium chloride 1.4mg lozenges
1203030B0AAAHAH
|
Benzocaine (Antiseptic lozenge/spray) | Benzocaine | Ear, Nose and Oropharynx | No data available |
|
Benzocaine 10mg / Dequalinium chloride 250microgram lozenges
1203030B0AAAEAE
|
Benzocaine (Antiseptic lozenge/spray) | Benzocaine | Ear, Nose and Oropharynx | No data available |
|
Benzocaine 125mg/5ml oral liquid
1203010C0AAAQAQ
|
Benzocaine (Systemic) | Benzocaine | Ear, Nose and Oropharynx | No data available |
|
Benzocaine 150mg/5ml oral liquid
1203010C0AAAKAK
|
Benzocaine (Systemic) | Benzocaine | Ear, Nose and Oropharynx | No data available |
|
Benzocaine 2.857% / Triclosan 0.057% spray
1303000B0AAAEAE
|
Benzocaine (Topical) | Benzocaine | Skin | No data available |
|
Benzocaine 2% / Chloroxylenol 0.106% oromucosal gel SF
1203010C0AAALAL
|
Benzocaine (Systemic) | Benzocaine | Ear, Nose and Oropharynx | No data available |
|
Benzocaine 2% / Mepyramine 2% spray
1303000B0AAAKAK
|
Benzocaine (Topical) | Benzocaine | Skin | No data available |
|
Benzocaine powder
190400000AAHNHN
|
Generic compound preparation BNF 1904000 | Other single substance preparations | Other Drugs and Preparations | No data available |
|
Benzoic acid 6% / Salicylic acid 3% cream
1310020V0AAADAD
|
Salicylic acid (Antifungal) | Salicylic acid | Skin | No data available |
|
Benzoyl peroxide 10% gel
1306010C0AAACAC
|
Benzoyl peroxide | Benzoyl peroxide | Skin | No data available |
|
Benzoyl peroxide 10% lotion
1306010C0AAAIAI
|
Benzoyl peroxide | Benzoyl peroxide | Skin | No data available |
|
Benzoyl peroxide 10% wash
1306010C0AAAJAJ
|
Benzoyl peroxide | Benzoyl peroxide | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.